Clinical Trials List
2024-02-12 - 2028-11-18
Phase II/III
Recruiting7
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈書慧 無
- Mei-Ju Chen 無
- Huann-Cheng Horng 無
- 楊思婷 無
- Yen-Hou Chang 無
- 楊思婷 無
- Yi-Jen Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳鵬宇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張文君 無
- 戴依柔 無
- YING-CHENG CHIANG 無
- 許恒誠 無
- 吳晉睿 無
- CHI-HAU CHEN CHI-HAU CHEN 無
- 施怡倫 無
- Ta-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yun-Hsin Tang 無
- HSIU-JUNG TUNG 無
- Ting-Chang Chang 無
- 黃彥綾 無
- Angel Chao 無
- 陳威君 無
- 黃寬仁 無
- Chyong-Huey Lai 無
- Min-Yu Chen 無
- Huei-Jean Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
33 participants
-
Global
860 participants
